However, a significant downregulation of p-mTOR/mTOR and p-Akt/Akt protein expression levels was observed at 250 and 500 μg/mL of CL treatment in the NSCLC cells (H460 and H292) compared with the untreated control (Figure 6A,B). This evidence concerns the gene MTOR and non-small cell lung carcinoma.